Published in Nat Rev Microbiol on June 25, 2012
The keystone-pathogen hypothesis. Nat Rev Microbiol (2012) 4.18
Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe (2013) 3.21
Microbes, microbiota, and colon cancer. Cell Host Microbe (2014) 2.06
Fusobacterium is associated with colorectal adenomas. PLoS One (2013) 1.99
Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease. Mod Pathol (2013) 1.95
The gut microbiota and host health: a new clinical frontier. Gut (2015) 1.91
A highly abundant bacteriophage discovered in the unknown sequences of human faecal metagenomes. Nat Commun (2014) 1.88
Intestinal inhibition of Atg7 prevents tumour initiation through a microbiome-influenced immune response and suppresses tumour growth. Nat Cell Biol (2015) 1.63
Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS One (2013) 1.62
The gut microbiota in conventional and serrated precursors of colorectal cancer. Microbiome (2016) 1.45
Epithelial calcineurin controls microbiota-dependent intestinal tumor development. Nat Med (2016) 1.42
Sequencing and beyond: integrating molecular 'omics' for microbial community profiling. Nat Rev Microbiol (2015) 1.41
Polymicrobial synergy and dysbiosis in inflammatory disease. Trends Mol Med (2014) 1.27
Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology. Oncogene (2013) 1.23
Colorectal carcinogenesis--update and perspectives. World J Gastroenterol (2014) 1.19
Bacterial oncogenesis in the colon. Future Microbiol (2013) 1.18
Adenomatous polyps are driven by microbe-instigated focal inflammation and are controlled by IL-10-producing T cells. Cancer Res (2013) 1.16
Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression. Mod Pathol (2014) 1.16
Gastrointestinal malignancy and the microbiome. Gastroenterology (2014) 1.07
Inflammation and colorectal cancer, when microbiota-host mutualism breaks. World J Gastroenterol (2014) 1.06
Fusobacterium nucleatum: a commensal-turned pathogen. Curr Opin Microbiol (2015) 1.04
Microbiota disbiosis is associated with colorectal cancer. Front Microbiol (2015) 1.02
Diversified pattern of the human colorectal cancer microbiome. Gut Pathog (2013) 1.01
Association of plasma endotoxin, inflammatory cytokines and risk of colorectal adenomas. BMC Cancer (2013) 1.00
Gut microbiota imbalance and colorectal cancer. World J Gastroenterol (2016) 0.99
HIV and the gut microbiota, partners in crime: breaking the vicious cycle to unearth new therapeutic targets. J Immunol Res (2015) 0.98
Segmented filamentous bacteria: commensal microbes with potential effects on research. Comp Med (2014) 0.98
Dietary patterns and colorectal cancer recurrence and survival: a cohort study. BMJ Open (2013) 0.95
Inter- and intra-individual variations in seasonal and daily stabilities of the human gut microbiota in Japanese. Arch Microbiol (2015) 0.94
Pharmacomicrobiomics: the impact of human microbiome variations on systems pharmacology and personalized therapeutics. OMICS (2014) 0.92
Colon Macrophages Polarized by Commensal Bacteria Cause Colitis and Cancer through the Bystander Effect. Transl Oncol (2013) 0.91
Inflammaging and cancer: a challenge for the Mediterranean diet. Nutrients (2015) 0.91
Gut microbiome and anticancer immune response: really hot Sh*t! Cell Death Differ (2014) 0.90
Microbiota impact on the epigenetic regulation of colorectal cancer. Trends Mol Med (2013) 0.90
Detection and differential diagnosis of colon cancer by a cumulative analysis of promoter methylation. Nat Commun (2012) 0.89
Dynamic microbe and molecule networks in a mouse model of colitis-associated colorectal cancer. Sci Rep (2014) 0.89
Dancing with the Stars: How Choreographed Bacterial Interactions Dictate Nososymbiocity and Give Rise to Keystone Pathogens, Accessory Pathogens, and Pathobionts. Trends Microbiol (2016) 0.89
Pathogenesis of intestinal Pseudomonas aeruginosa infection in patients with cancer. Front Cell Infect Microbiol (2014) 0.89
Cancer-promoting effects of microbial dysbiosis. Curr Oncol Rep (2014) 0.88
Inflammatory networks underlying colorectal cancer. Nat Immunol (2016) 0.88
Fecal Microbiota Characteristics of Patients with Colorectal Adenoma Detected by Screening: A Population-based Study. EBioMedicine (2015) 0.87
Bacterial responses to a simulated colon tumor microenvironment. Mol Cell Proteomics (2012) 0.86
Potential role of gastrointestinal microbiota composition in prostate cancer risk. Infect Agent Cancer (2013) 0.86
Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One (2016) 0.86
Significance of infectious agents in colorectal cancer development. J Cancer (2013) 0.85
Fap2 of Fusobacterium nucleatum is a galactose-inhibitable adhesin involved in coaggregation, cell adhesion, and preterm birth. Infect Immun (2015) 0.84
Diet, microorganisms and their metabolites, and colon cancer. Nat Rev Gastroenterol Hepatol (2016) 0.83
The cytotoxic necrotizing factor 1 from E. coli: a janus toxin playing with cancer regulators. Toxins (Basel) (2013) 0.83
Microbial dysbiosis and colon carcinogenesis: could colon cancer be considered a bacteria-related disease? Therap Adv Gastroenterol (2013) 0.83
Fermentation supernatants of Lactobacillus delbrueckii inhibit growth of human colon cancer cells and induce apoptosis through a caspase 3-dependent pathway. Oncol Lett (2014) 0.83
Gut microbiota: Colorectal cancer-driven by inflammation and gut bacteria? Nat Rev Gastroenterol Hepatol (2012) 0.83
Targeting aberrant colon cancer-specific DNA methylation with lipoteichoic acid-deficient Lactobacillus acidophilus. Gut Microbes (2012) 0.83
Co-occurrence of driver and passenger bacteria in human colorectal cancer. Gut Pathog (2014) 0.83
Protective links between vitamin D, inflammatory bowel disease and colon cancer. World J Gastroenterol (2016) 0.82
Microbiome, inflammation, and cancer. Cancer J (2014) 0.82
Mucosal adherent bacterial dysbiosis in patients with colorectal adenomas. Sci Rep (2016) 0.81
Immune reaction and colorectal cancer: friends or foes? World J Gastroenterol (2014) 0.81
Colon cancer-associated B2 Escherichia coli colonize gut mucosa and promote cell proliferation. World J Gastroenterol (2014) 0.81
Factors Determining Colorectal Cancer: The Role of the Intestinal Microbiota. Front Oncol (2015) 0.80
Gut Microbiota and Colorectal Cancer. Gastrointest Tumors (2015) 0.80
The microbiome and colorectal neoplasia: environmental modifiers of dysbiosis. Curr Gastroenterol Rep (2013) 0.79
Gut microbiota, inflammation and colorectal cancer. Genes Dis (2016) 0.79
Historical review of the causes of cancer. World J Clin Oncol (2016) 0.79
Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer. World J Gastroenterol (2016) 0.79
Insulin resistance is associated with specific gut microbiota in appendix samples from morbidly obese patients. Am J Transl Res (2016) 0.78
The interplay between the microbiome and the adaptive immune response in cancer development. Therap Adv Gastroenterol (2016) 0.78
Mouse models of colorectal cancer as preclinical models. Bioessays (2015) 0.78
Targeting colorectal cancer-associated bacteria: A new area of research for personalized treatments. Gut Microbes (2016) 0.78
Metabolic and Community Synergy of Oral Bacteria in Colorectal Cancer. mSphere (2016) 0.78
Gut microbiota and colorectal cancer. Eur J Clin Microbiol Infect Dis (2017) 0.78
"Messieurs, c'est les microbes qui auront le dernier mot": Gentlemen, it is the microbes who have the last word (Louis Pasteur)-Fusobacterium nucleatum protect tumors from killing by immune cells. Oncoimmunology (2015) 0.77
Effects of a high fat diet on intestinal microbiota and gastrointestinal diseases. World J Gastroenterol (2016) 0.77
Microbiota and immune responses in colon cancer: more to learn. Cancer J (2014) 0.77
Bioactive compounds produced by gut microbial tannase: implications for colorectal cancer development. Front Microbiol (2014) 0.77
Impact of a High-Fat or High-Fiber Diet on Intestinal Microbiota and Metabolic Markers in a Pig Model. Nutrients (2016) 0.77
Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology. World J Gastroenterol (2015) 0.76
Mechanistic roles of epithelial and immune cell signaling during the development of colitis-associated cancer. Cancer Res Front (2016) 0.76
Triterpenoid herbal saponins enhance beneficial bacteria, decrease sulfate-reducing bacteria, modulate inflammatory intestinal microenvironment and exert cancer preventive effects in ApcMin/+ mice. Oncotarget (2016) 0.76
Chemopreventive Strategies for Inflammation-Related Carcinogenesis: Current Status and Future Direction. Int J Mol Sci (2017) 0.75
The effect of perioperative probiotics treatment for colorectal cancer: short-term outcomes of a randomized controlled trial. Oncotarget (2016) 0.75
Role of the Microbiota in Colorectal Cancer: Updates on Microbial Associations and Therapeutic Implications. Biores Open Access (2016) 0.75
Mitigating colon cancer with a novel strain of Lactobacillus acidophilus: a (re-)balancing act. Immunotherapy (2012) 0.75
Reactivation of dormant anti-tumor immunity - a clinical perspective of therapeutic immune checkpoint modulation. Cell Commun Signal (2017) 0.75
Role of Fusobacteria in the serrated pathway of colorectal carcinogenesis. Sci Rep (2016) 0.75
Evolutionary biologic changes of gut microbiota in an 'adenoma-carcinoma sequence' mouse colorectal cancer model induced by 1, 2-Dimethylhydrazine. Oncotarget (2016) 0.75
Association of colorectal cancer with pathogenic Escherichia coli: Focus on mechanisms using optical imaging. World J Clin Oncol (2016) 0.75
Colonization with enterotoxigenic Bacteroides fragilis is associated with early-stage colorectal neoplasia. PLoS One (2017) 0.75
Host-Microbiome Interaction and Cancer: Potential Application in Precision Medicine. Front Physiol (2016) 0.75
Polymorphisms in the CHIT1 gene: Associations with colorectal cancer. Oncotarget (2016) 0.75
Editorial on "Cancer and the microbiota" published in Science. Ann Transl Med (2015) 0.75
Identification of a characteristic vascular belt zone in human colorectal cancer. PLoS One (2017) 0.75
Current Hypothesis for the Relationship between Dietary Rice Bran Intake, the Intestinal Microbiota and Colorectal Cancer Prevention. Nutrients (2016) 0.75
The Expression of Toll-like Receptors in Normal Human and Murine Gastrointestinal Organs and the Effect of Microbiome and Cancer. J Histochem Cytochem (2016) 0.75
Fulfilling the Promise of Microbiomics to Revolutionize Medicine. J Microbiol Exp (2015) 0.75
Insights into the role of the intestinal microbiota in colon cancer. Therap Adv Gastroenterol (2017) 0.75
Comparisons of Gut Microbiota Among Healthy Control, Patients With Conventional Adenoma, Sessile Serrated Adenoma, and Colorectal Cancer. J Cancer Prev (2017) 0.75
Short-term treatment with eicosapentaenoic acid improves inflammation and affects colonic differentiation markers and microbiota in patients with ulcerative colitis. Sci Rep (2017) 0.75
Cancer associated faecal microbial markers in colorectal cancer detection. Int J Cancer (2017) 0.75
Streptococcus gallolyticus subsp. gallolyticus promotes colorectal tumor development. PLoS Pathog (2017) 0.75
Cecal microbiota association with tumor load in a colorectal cancer mouse model. Microb Ecol Health Dis (2017) 0.75
Hallmarks of cancer: the next generation. Cell (2011) 140.01
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer (2010) 90.16
Cancer statistics, 2009. CA Cancer J Clin (2009) 83.57
Diversity of the human intestinal microbial flora. Science (2005) 49.64
A human gut microbial gene catalogue established by metagenomic sequencing. Nature (2010) 43.63
Metagenomic analysis of the human distal gut microbiome. Science (2006) 29.76
Transforming growth factor-beta induces development of the T(H)17 lineage. Nature (2006) 25.91
Bacterial community variation in human body habitats across space and time. Science (2009) 24.84
Enterotypes of the human gut microbiome. Nature (2011) 24.36
The cancer genome. Nature (2009) 23.13
Wnt signalling in stem cells and cancer. Nature (2005) 19.26
Crypt stem cells as the cells-of-origin of intestinal cancer. Nature (2008) 11.66
Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet (2007) 9.88
Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun (1998) 7.86
A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med (2009) 7.45
Molecular genetics of colorectal cancer. Annu Rev Pathol (2011) 7.24
The multistep nature of cancer. Trends Genet (1993) 6.12
Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res (2011) 5.97
Association of Streptococcus bovis with carcinoma of the colon. N Engl J Med (1977) 5.86
Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res (2011) 5.58
Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther (2007) 5.47
Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J (2010) 5.43
Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci U S A (2010) 5.02
Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science (2006) 4.58
The core gut microbiome, energy balance and obesity. J Physiol (2009) 4.45
Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res (2009) 3.50
Oral multispecies biofilm development and the key role of cell-cell distance. Nat Rev Microbiol (2010) 3.47
Clinical practice. Screening for colorectal cancer. N Engl J Med (2009) 3.25
Assembly of the human intestinal microbiota. Trends Ecol Evol (2006) 3.21
Genome sequence and analysis of the oral bacterium Fusobacterium nucleatum strain ATCC 25586. J Bacteriol (2002) 3.18
Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc Natl Acad Sci U S A (2010) 3.18
Diversity of the human gastrointestinal tract microbiota revisited. Environ Microbiol (2007) 3.00
Extracellular superoxide production by Enterococcus faecalis promotes chromosomal instability in mammalian cells. Gastroenterology (2006) 2.81
A two-step model for colon adenoma initiation and progression caused by APC loss. Cell (2009) 2.80
Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. PLoS One (2009) 2.79
Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas. Gut Microbes (2010) 2.70
Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host. Inflamm Bowel Dis (2011) 2.62
Profiling the humoral immune response in colon cancer patients: diagnostic antigens from Streptococcus bovis. Int J Cancer (2006) 2.50
The battle for iron between bacterial pathogens and their vertebrate hosts. PLoS Pathog (2010) 2.39
A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer. Clin Microbiol Infect (2006) 2.32
Towards the human colorectal cancer microbiome. PLoS One (2011) 2.30
Association of enterotoxigenic Bacteroides fragilis infection with inflammatory diarrhea. Clin Infect Dis (2008) 2.29
Enterotoxigenic Bacteroides fragilis: a rogue among symbiotes. Clin Microbiol Rev (2009) 2.09
Novel clues on the specific association of Streptococcus gallolyticus subsp gallolyticus with colorectal cancer. J Infect Dis (2011) 2.05
The Human Microbiome Project in 2011 and beyond. Cell Host Microbe (2011) 1.89
Mucosa-associated bacterial diversity in relation to human terminal ileum and colonic biopsy samples. Appl Environ Microbiol (2007) 1.84
Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies. World J Gastroenterol (2008) 1.79
Clinical practice. Bacterial diarrhea. N Engl J Med (2009) 1.78
Enterococcus faecalis produces extracellular superoxide and hydrogen peroxide that damages colonic epithelial cell DNA. Carcinogenesis (2002) 1.76
Clinical Importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis. Clin Infect Dis (2011) 1.74
Promotion of intestinal carcinogenesis by Streptococcus bovis. Carcinogenesis (2000) 1.71
Intestinal neoplasia in the ApcMin mouse: independence from the microbial and natural killer (beige locus) status. Cancer Res (1997) 1.67
Gastrointestinal microflora, food components and colon cancer prevention. J Nutr Biochem (2009) 1.65
Th17 cytokines and the gut mucosal barrier. J Clin Immunol (2010) 1.64
Genome sequence of Streptococcus gallolyticus: insights into its adaptation to the bovine rumen and its ability to cause endocarditis. J Bacteriol (2010) 1.64
Colon cancer stem cells. J Mol Med (Berl) (2009) 1.53
Perspective: alpha-bugs, their microbial partners, and the link to colon cancer. J Infect Dis (2010) 1.53
Colon cancer: a civilization disorder. Dig Dis (2011) 1.49
Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis. Proc Natl Acad Sci U S A (2011) 1.40
Pyrosequencing-based analysis of the mucosal microbiota in healthy individuals reveals ubiquitous bacterial groups and micro-heterogeneity. PLoS One (2011) 1.38
Bacteroides fragilis toxin stimulates intestinal epithelial cell shedding and gamma-secretase-dependent E-cadherin cleavage. J Cell Sci (2007) 1.33
The Fusobacterium nucleatum outer membrane protein RadD is an arginine-inhibitable adhesin required for inter-species adherence and the structured architecture of multispecies biofilm. Mol Microbiol (2008) 1.32
Enterococcus faecalis induces aneuploidy and tetraploidy in colonic epithelial cells through a bystander effect. Cancer Res (2008) 1.29
Epithelial barrier: an interface for the cross-communication between gut flora and immune system. Immunol Rev (2012) 1.27
New perspectives on APC control of cell fate and proliferation in colorectal cancer. Cell Cycle (2009) 1.21
The Bacteroides fragilis toxin binds to a specific intestinal epithelial cell receptor. Infect Immun (2006) 1.20
Nuclear translocation of beta-catenin in hereditary and carcinogen-induced intestinal adenomas. Carcinogenesis (1998) 1.16
Molecular characterization of the bacteria adherent to human colorectal mucosa. J Appl Microbiol (2006) 1.15
Butyrate and Wnt signaling: a possible solution to the puzzle of dietary fiber and colon cancer risk? Cell Cycle (2008) 1.14
Molecular detection, quantification, and isolation of Streptococcus gallolyticus bacteria colonizing colorectal tumors: inflammation-driven potential of carcinogenesis via IL-1, COX-2, and IL-8. Mol Cancer (2010) 1.12
Infectious causes of cancer and their detection. J Biol (2009) 1.11
Progression of atrophic gastritis and intestinal metaplasia drives Helicobacter pylori out of the gastric mucosa. Dig Dis Sci (2006) 1.11
The search for infectious causes of human cancers: where and why (Nobel lecture). Angew Chem Int Ed Engl (2009) 1.08
Gut bacteria in health and disease: a survey on the interface between intestinal microbiology and colorectal cancer. Biol Rev Camb Philos Soc (2012) 1.06
Unusual bacterial infections and colorectal carcinoma--Streptococcus bovis and Clostridium septicum: report of three cases. Dis Colon Rectum (2006) 1.05
Helicobacter: the ease and difficulty of a new discovery (Nobel lecture). ChemMedChem (2006) 1.05
Fusobacterium nucleatum: an emerging gut pathogen? Gut Microbes (2011) 1.04
Bacterial infection of Smad3/Rag2 double-null mice with transforming growth factor-beta dysregulation as a model for studying inflammation-associated colon cancer. Am J Pathol (2009) 1.04
Slackia equolifaciens sp. nov., a human intestinal bacterium capable of producing equol. Int J Syst Evol Microbiol (2009) 1.02
Human distal gut microbiome. Environ Microbiol (2011) 1.01
Enterotoxigenic Bacteroides fragilis (ETBF)-mediated colitis in Min (Apc+/-) mice: a human commensal-based murine model of colon carcinogenesis. Cell Cycle (2010) 0.98
Equol induces apoptosis through cytochrome c-mediated caspases cascade in human breast cancer MDA-MB-453 cells. Chem Biol Interact (2008) 0.94
A blood donor with bacteraemia. Lancet (2005) 0.94
Ultrastructure of surface components of Streptococcus gallolytics (S. bovis) strains of differing virulence isolated from pigeons. Microbiology (1999) 0.91
Host genetics and environmental factors regulate ecological succession of the mouse colon tissue-associated microbiota. PLoS One (2012) 0.90
Increased exposure to bacterial antigen RpL7/L12 in early stage colorectal cancer patients. Cancer (2010) 0.89
Adherence to streptococci facilitates Fusobacterium nucleatum integration into an oral microbial community. Microb Ecol (2011) 0.88
Identification of biomarkers for colorectal cancer through proteomics-based approaches. Expert Rev Proteomics (2010) 0.87
Subtyping of Streptococcus bovis group bacteria is needed to fully understand the clinical value of Streptococcus gallolyticus (S. bovis biotype I) infection as early sign of colonic malignancy. Int J Clin Pract (2012) 0.82
Selective antibody response to Streptococcus gallolyticus pilus proteins in colorectal cancer patients. Cancer Prev Res (Phila) (2011) 0.82
Association between rural residency, group D streptococcal endocarditis and colon cancer? Clin Microbiol Infect (2007) 0.82
Gut microbiota composition correlates with diet and health in the elderly. Nature (2012) 6.94
Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci U S A (2010) 5.02
Comparative analysis of pyrosequencing and a phylogenetic microarray for exploring microbial community structures in the human distal intestine. PLoS One (2009) 4.93
Deciphering the evolution and metabolism of an anammox bacterium from a community genome. Nature (2006) 4.06
Nitrite-driven anaerobic methane oxidation by oxygenic bacteria. Nature (2010) 4.06
Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk. Gut (2011) 3.42
Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease. J Clin Microbiol (2006) 2.93
Metagenomics and future perspectives in virus discovery. Curr Opin Virol (2012) 2.92
Diversity of bifidobacteria within the infant gut microbiota. PLoS One (2012) 2.71
Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome. Proc Natl Acad Sci U S A (2008) 2.53
Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol Psychiatry (2008) 2.52
Towards the human colorectal cancer microbiome. PLoS One (2011) 2.30
Genome-wide profiling of p63 DNA-binding sites identifies an element that regulates gene expression during limb development in the 7q21 SHFM1 locus. PLoS Genet (2010) 2.14
Genome trees and the nature of genome evolution. Annu Rev Microbiol (2005) 2.12
The human urinary microbiome; bacterial DNA in voided urine of asymptomatic adults. Front Cell Infect Microbiol (2013) 1.87
Micro-eukaryotic diversity of the human distal gut microbiota: qualitative assessment using culture-dependent and -independent analysis of faeces. ISME J (2008) 1.70
Metabonomic and microbiological analysis of the dynamic effect of vancomycin-induced gut microbiota modification in the mouse. J Proteome Res (2008) 1.67
Human methanogen diversity and incidence in healthy and diseased colonic groups using mcrA gene analysis. BMC Microbiol (2008) 1.56
Gut microbiota composition and activity in relation to host metabolic phenotype and disease risk. Cell Metab (2012) 1.55
Transposon-aided capture (TRACA) of plasmids resident in the human gut mobile metagenome. Nat Methods (2006) 1.50
The metagenome of the marine anammox bacterium 'Candidatus Scalindua profunda' illustrates the versatility of this globally important nitrogen cycle bacterium. Environ Microbiol (2012) 1.44
Microbiomic analysis of the bifidobacterial population in the human distal gut. ISME J (2009) 1.43
Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis. Environ Microbiol (2008) 1.42
A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome. Dig Dis Sci (2009) 1.39
Marine metagenomics: strategies for the discovery of novel enzymes with biotechnological applications from marine environments. Microb Cell Fact (2008) 1.32
Culture-independent analysis of desulfovibrios in the human distal colon of healthy, colorectal cancer and polypectomized individuals. FEMS Microbiol Ecol (2009) 1.31
Species variation in the fecal metabolome gives insight into differential gastrointestinal function. J Proteome Res (2007) 1.30
Isolation and analysis of bacteria with antimicrobial activities from the marine sponge Haliclona simulans collected from Irish waters. Mar Biotechnol (NY) (2008) 1.30
Association between Streptococcus bovis and colon cancer. J Clin Microbiol (2009) 1.29
Horizontal gene transfer from Bacteria to rumen Ciliates indicates adaptation to their anaerobic, carbohydrates-rich environment. BMC Genomics (2006) 1.27
Practical and theoretical advances in predicting the function of a protein by its phylogenetic distribution. J R Soc Interface (2008) 1.24
Discovery of a HapE mutation that causes azole resistance in Aspergillus fumigatus through whole genome sequencing and sexual crossing. PLoS One (2012) 1.22
Diversity of microbes associated with the marine sponge, Haliclona simulans, isolated from Irish waters and identification of polyketide synthase genes from the sponge metagenome. Environ Microbiol (2008) 1.20
Identification of a novel human papillomavirus by metagenomic analysis of samples from patients with febrile respiratory illness. PLoS One (2013) 1.19
Iron availability increases the pathogenic potential of Salmonella typhimurium and other enteric pathogens at the intestinal epithelial interface. PLoS One (2012) 1.12
Comparative metagenomic analysis of plasmid encoded functions in the human gut microbiome. BMC Genomics (2010) 1.11
Combining de novo and reference-guided assembly with scaffold_builder. Source Code Biol Med (2013) 1.11
The organellar genome and metabolic potential of the hydrogen-producing mitochondrion of Nyctotherus ovalis. Mol Biol Evol (2011) 1.09
Taxonomic and functional microbial signatures of the endemic marine sponge Arenosclera brasiliensis. PLoS One (2012) 1.02
Mobile genetic elements of the human gastrointestinal tract: potential for spread of antibiotic resistance genes. Gut Microbes (2013) 1.02
Mass spectrometry analysis of hepcidin peptides in experimental mouse models. PLoS One (2011) 1.00
Experimental bariatric surgery in rats generates a cytotoxic chemical environment in the gut contents. Front Microbiol (2011) 1.00
Conservation of divergent transcription in fungi. Trends Genet (2008) 0.99
Functional metagenomics reveals novel salt tolerance loci from the human gut microbiome. ISME J (2012) 0.97
Metagenomic approaches to exploit the biotechnological potential of the microbial consortia of marine sponges. Appl Microbiol Biotechnol (2007) 0.97
The gut microbiome: the role of a virtual organ in the endocrinology of the host. J Endocrinol (2013) 0.95
Phylogenetic diversity and antimicrobial activities of fungi associated with Haliclona simulans isolated from Irish coastal waters. Mar Biotechnol (NY) (2008) 0.94
Asymmetric relationships between proteins shape genome evolution. Genome Biol (2009) 0.94
Oxygen minimum zones harbour novel viral communities with low diversity. Environ Microbiol (2012) 0.93
Pyrosequencing of 16S rRNA gene amplicons to study the microbiota in the gastrointestinal tract of carp (Cyprinus carpio L.). AMB Express (2011) 0.92
Pharmacomicrobiomics: the impact of human microbiome variations on systems pharmacology and personalized therapeutics. OMICS (2014) 0.92
Ultra-deep pyrosequencing of pmoA amplicons confirms the prevalence of Methylomonas and Methylocystis in Sphagnum mosses from a Dutch peat bog. Environ Microbiol Rep (2011) 0.91
The mitochondrial genomes of the ciliates Euplotes minuta and Euplotes crassus. BMC Genomics (2009) 0.90
Microbial taxonomy in the post-genomic era: rebuilding from scratch? Arch Microbiol (2014) 0.90
Development of the first marmoset-specific DNA microarray (EUMAMA): a new genetic tool for large-scale expression profiling in a non-human primate. BMC Genomics (2007) 0.89
Macronuclear genome structure of the ciliate Nyctotherus ovalis: single-gene chromosomes and tiny introns. BMC Genomics (2008) 0.87
Draft Genome Sequence of Anammox Bacterium "Candidatus Scalindua brodae," Obtained Using Differential Coverage Binning of Sequencing Data from Two Reactor Enrichments. Genome Announc (2015) 0.87
Bacterial responses to a simulated colon tumor microenvironment. Mol Cell Proteomics (2012) 0.86
Chemoembolisation of rat colorectal liver metastases with drug eluting beads loaded with irinotecan or doxorubicin. Clin Exp Metastasis (2008) 0.85
Degradation of 4-fluorophenol by Arthrobacter sp. strain IF1. Appl Microbiol Biotechnol (2008) 0.85
Minimum taxonomic criteria for bacterial genome sequence depositions and announcements. J Microbiol Methods (2012) 0.83
Genome-wide study of the defective sucrose fermenter strain of Vibrio cholerae from the Latin American cholera epidemic. PLoS One (2012) 0.81
Accessing the mobile metagenome of the human gut microbiota. Mol Biosyst (2007) 0.81
Genome sequence of the human pathogen Vibrio cholerae Amazonia. J Bacteriol (2011) 0.80
Mining the human gut microbiome for novel stress resistance genes. Gut Microbes (2012) 0.79
The contribution of 'omic'-based approaches to the study of enhanced biological phosphorus removal microbiology. FEMS Microbiol Ecol (2009) 0.79
A robust plate assay for detection of extracellular microbial protease activity in metagenomic screens and pure cultures. J Microbiol Methods (2012) 0.78
Partial associations of dietary iron, smoking and intestinal bacteria with colorectal cancer risk. Nutr Cancer (2013) 0.78
Genome sequences of the ethanol-tolerant Lactobacillus vini strains LMG 23202T and JP7.8.9. J Bacteriol (2012) 0.78
Genome-wide screening in human growth plates during puberty in one patient suggests a role for RUNX2 in epiphyseal maturation. J Endocrinol (2011) 0.77
Bounds on the distribution of the number of gaps when circles and lines are covered by fragments: theory and practical application to genomic and metagenomic projects. BMC Bioinformatics (2007) 0.77
Copper tolerance and distribution of epibiotic bacteria associated with giant kelp Macrocystis pyrifera in southern California. Ecotoxicology (2015) 0.77
Comparative genomics of 274 Vibrio cholerae genomes reveals mobile functions structuring three niche dimensions. BMC Genomics (2014) 0.77
Metabolic, immune, and gut microbial signals mount a systems response to Leishmania major infection. J Proteome Res (2014) 0.76
Too much fat for the gut's microbiota. Gut (2012) 0.76
Functional characterisation of Lp_2714, an EAL-domain protein from Lactobacillus plantarum. Biochem Biophys Res Commun (2011) 0.76
Inhibition of the growth of Bacillus subtilis DSM10 by a newly discovered antibacterial protein from the soil metagenome. Bioengineered (2015) 0.75
Current functional metagenomic approaches only expand the existing protease sequence space, but does not presently add any novelty to it. Curr Microbiol (2014) 0.75
Characterization of the electrochemical behavior of gastrointestinal fluids using a multielectrode sensor probe. IEEE Trans Biomed Eng (2011) 0.75
Isolation and characterization of a diverse group of phenylacetic acid degrading microorganisms from pristine soil. Chemosphere (2005) 0.75
Isolation of novel bacteria able to degrade alpha-halocarboxylic acids by enrichment from environmental samples. Chemosphere (2005) 0.75